-
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019
Mar 10, 2025, 14:00 PM -
Depression Among Rheumatoid Arthritis Patients Using the Medical Expenditure Panel Survey Database
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States
Mar 10, 2025, 14:00 PM -
Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK
Mar 10, 2025, 14:00 PM -
Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Transient Elastography for Significant Fibrosis Detection in Patients With Diabetes Mellitus in Thailand
Mar 10, 2025, 14:00 PM -
Use of Sensitivity Analysis to Address Potential Missing Data and Selection Bias from Linked Genomics Datasets in a Real-World Study of Patients Receiving Immune-Checkpoint Inhibitors for Metastatic Melanoma
Mar 10, 2025, 14:00 PM -
Conceptualisation and the Role of Market Access in Pharmaceutical Industry: A Qualitative Study
Mar 10, 2025, 14:00 PM -
Treatment Patterns, Clinical Outcomes, Health Care Resource Use and Costs in Older Adults with Malignant Pleural Mesothelioma in the United States
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Treatment Patterns Post-CAR T Cell Therapy in Patients With Hematologic Malignancies: A Real-World US Study
Mar 10, 2025, 14:00 PM -
Overall Survival in People Living with HIV, Who Experienced Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM -
Evaluation of Chronic Conditions and Severe Outcomes in Adults Aged 18-59 Years With Medically Attended RSV Illness Using U.S. Commercial Claims Data
Mar 10, 2025, 14:00 PM -
Characterization of Patients With Desmoid Tumors (DT) and Their Treatment Patterns Within an Academic Health System in the United States
Mar 10, 2025, 14:00 PM -
Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic Triple Negative Breast Cancer (mTNBC)
Mar 10, 2025, 14:00 PM -
Relationship Between Event-Free Survival (EFS) and Overall Survival (OS) in Newly Diagnosed Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Mar 10, 2025, 14:00 PM
